Drug Target Discovery Technology
Scientific Animation | Scientific Storytelling & Product Education
Phoremost’s technology aims to discover drug targets that remain intractable or undetected using conventional technologies, facilitating drug development for diseases such as cancer. Their novel SITESEEKER® platform uses PROTEINi® (or protein interference) – a new phenotypic screening method that identifies unexpected druggable sites that aren’t apparent with other technologies.
PROTEINi® libraries encode millions of different proteins allowing identification of target-interaction sites throughout the whole proteome. This mechanism of action (MoA) animation shows how PROTEINi® uses phenotypic screening to rapidly identify the key target-interaction sites involved in the disease being studied. This allows the discovery of novel drug targets including targets that were previously deemed ‘undruggable’.
This animation appeared on the Phoremost technology page to showcase the potential of PROTEINi® technology for drug discovery programs.